CCL2 and pulmonary fibrosis: Although the use of various cell populations to attenuate the progression of pulmonary fibrosis, with varying degrees of success, has been previously described, we are the first to demonstrate that AFSC directly respond to increased CCL2 gradients found in injured lung BAL.